Table of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. CRISPR Gene Editing Market: By Product Type Trends, Size, and Future Outlook
- By Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Product Type Definitions, Technology Landscape
- By Product Type Market Drivers
- Product Launches
- Technology Launches
- By Product Type Market Restraints
Chapter 4. CRISPR Gene Editing Market: By Application Trends, Size, and Future Outlook
- By Application Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Application Definitions, Technology Landscape
- By Application Market Drivers
- Product Launches
- Technology Launches
- By Application Market Restraints
Chapter 5. CRISPR Gene Editing Market: By End-User Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
Chapter 6. CRISPR Gene Editing Market: By Delivery Mode Trends, Size, and Future Outlook
- By Delivery Mode Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Delivery Mode Definitions, Technology Landscape
- By Delivery Mode Market Drivers
- Product Launches
- Technology Launches
- By Delivery Mode Market Restraints
Chapter 7. CRISPR Gene Editing Market: By Technology Trends, Size, and Future Outlook
- By Technology Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Technology Definitions, Technology Landscape
- By Technology Market Drivers
- Product Launches
- Technology Launches
- By Technology Market Restraints
Chapter 8. CRISPR Gene Editing Market: By Service Type Trends, Size, and Future Outlook
- By Service Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Service Type Definitions, Technology Landscape
- By Service Type Market Drivers
- Product Launches
- Technology Launches
- By Service Type Market Restraints
Chapter 9. CRISPR Gene Editing Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Trends, Market Size (US$), CAGR (%), and Future Outlook
Chapter 10. CRISPR Gene Editing Market: Competitive Landscape
- CRISPR Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Editas Medicine
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Intellia Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Caribou Biosciences
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Vertex Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sangamo Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Precision BioSciences
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Casebia Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Beam Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Excision BioTherapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Arbor Biotechnologies
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Graphite Bio
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Inari Agriculture
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pairwise Plants
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Tropic Biosciences
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Cibus
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Benson Hill Biosystems
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Yield10 Bioscience
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer (Joyn Bio)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Syngenta (Calyxt)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the CRISPR Gene Editing industry is USD 1.2 billion.
Increasing prevalence of genetic disorders, rising demand for personalized medicine, advancements in gene sequencing technologies, growing research and development activities, and expanding applications in various fields.
Ethical and regulatory concerns, high cost of CRISPR therapies, technical challenges in gene editing, limited expertise and infrastructure, and potential off-target effects.
The leading component segment in the CRISPR Gene Editing Market is the vector-based CRISPR products segment, widely used in gene therapy and research applications.
CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences, Vertex Pharmaceuticals, Sangamo Therapeutics, Precision BioSciences, Casebia Therapeutics, Beam Therapeutics, and Excision BioTherapeutics.
The CRISPR Gene Editing Market is expected to grow at a CAGR of 32.1% during the forecast period, and North America is expected to lead the market.
Increasing prevalence of genetic disorders, rising demand for personalized medicine, advancements in gene sequencing technologies, growing research and development activities, expanding applications in various fields, and increasing investments and funding.